26-SEP-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES -- ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
BREAST 1152 18 939 86 1047 166 1011
ERLYTX 75 1 52 1 12 6 37
GI 168 3 157 13 158 26 158
GU 383 13 678 43 524 89 542
LEUK 161 4 209 17 207 32 195
LUNG 202 3 157 13 158 30 183
LYMPH 424 6 313 32 390 68 414
MELAN 7 0 0 0 0 0 0
MMYEL 112 2 104 10 122 19 116
MULT 51 1 52 2 24 3 18
OTHER 47 0 0 0 0 2 12
Total 2782 51 2661 217 2642 441 2686

26-SEP-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

NON-THERAPEUTIC STUDIES -- ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
CCD 205 5 261 19 231 37 225
ERLYTX 2 0 0 0 0 0 0
GI 1 0 0 0 0 1 6
GU 5 1 52 3 37 3 18
LEUK 616 14 730 54 657 108 657
LUNG 370 10 522 28 341 55 335
OTHER 15 0 0 3 37 7 43
PEOLC 71 0 0 0 0 1 6
PREV 227 4 209 12 146 23 140
SXQOL 657 13 678 51 621 101 615
Total 2169 47 2452 170 2070 336 2045

26-SEP-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
BREAST 1152 18 939 86 1047 166 1011
CCD 205 5 261 19 231 37 225
ERLYTX 77 1 52 1 12 6 37
GI 169 3 157 13 158 27 164
GU 388 14 730 46 560 92 560
LEUK 777 18 939 71 864 140 852
LUNG 572 13 678 41 499 85 517
LYMPH 424 6 313 32 390 68 414
MELAN 7 0 0 0 0 0 0
MMYEL 112 2 104 10 122 19 116
MULT 51 1 52 2 24 3 18
OTHER 62 0 0 3 37 9 55
PEOLC 71 0 0 0 0 1 6
PREV 227 4 209 12 146 23 140
SXQOL 657 13 678 51 621 101 615
Total 4951 98 5112 387 4711 777 4730

26-SEP-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES - ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
BREAST 703 8 417 42 511 83 505
ERLYTX 53 1 52 1 12 4 24
GI 127 1 52 11 134 23 140
GU 282 7 365 27 329 59 359
LEUK 99 1 52 8 97 17 103
LUNG 128 1 52 10 122 22 134
LYMPH 276 4 209 20 244 43 262
MELAN 7 0 0 0 0 0 0
MMYEL 61 1 52 4 49 9 55
MULT 20 1 52 1 12 1 6
OTHER 47 0 0 0 0 2 12
Total 1803 25 1303 124 1510 263 1600

26-SEP-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

NON-THERAPEUTIC STUDIES - ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
CCD 154 4 209 17 207 27 164
ERLYTX 2 0 0 0 0 0 0
GI 1 0 0 0 0 1 6
GU 4 0 0 2 24 2 12
LEUK 250 5 261 18 219 37 225
LUNG 225 8 417 21 256 39 237
OTHER 15 0 0 3 37 7 43
PEOLC 57 0 0 0 0 1 6
PREV 227 4 209 12 146 23 140
SXQOL 481 12 626 35 426 77 469
Total 1416 33 1722 108 1315 214 1302

26-SEP-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
BREAST 894 11 574 64 779 124 755
CCD 175 3 157 12 146 26 158
ERLYTX 55 1 52 1 12 4 24
GI 140 1 52 15 183 28 170
GU 320 7 365 30 365 71 432
LEUK 352 6 313 26 317 56 341
LUNG 382 8 417 36 438 66 402
LYMPH 276 4 209 20 244 43 262
MELAN 7 0 0 0 0 0 0
MMYEL 61 1 52 4 49 9 55
MULT 41 1 52 4 49 10 61
OTHER 135 0 0 3 37 9 55
PEOLC 60 1 52 2 24 3 18
PREV 227 4 209 12 146 23 140
SXQOL 481 12 626 35 426 77 469
Total 3606 60 3130 264 3215 549 3342

26-SEP-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES COORDINATED BY SWOG

ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
BREAST 984 17 887 82 998 156 950
ERLYTX 70 1 52 1 12 6 37
GI 101 3 157 8 97 16 97
GU 274 11 574 29 353 65 396
LEUK 131 4 209 15 183 28 170
LUNG 178 3 157 12 146 27 164
LYMPH 347 5 261 28 341 52 317
MMYEL 99 2 104 10 122 18 110
MULT 51 1 52 2 24 3 18
Total 2235 47 2453 187 2276 371 2259

26-SEP-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS ONLY

Inst. Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
Member 1876 23 1200 127 1546 274 1668
AFFIL 129 1 52 4 49 8 49
CCOP/NCORP 1214 34 1774 101 1230 195 1187
Non-SWOG 1731 39 2035 154 1875 299 1820
Total 4950 97 5061 386 4700 776 4724

26-SEP-2026 6:11

STUDIES OPENED THIS MONTH

ADMIN STUDYID STNAME REGTYPE Opened? Open Date
LEUK S2507 ALL/ALAL, KMT2A-trans, Blina +/- Revumenib 1 Y 22-SEP-26

26-SEP-2026 6:11

STUDIES CLOSED THIS MONTH

ADMIN STUDYID STNAME REGTYPE Opened? Open Date
ERLYTX SN2426 cSCC, IC Met/Inop, Amivantamab v Cetuximab 1 T 27-AUG-26
SXQOL NRG-CC013 HN Squamous Cell, Rec Chemo, BMX 1 E 23-SEP-26

26-SEP-2026 6:11

STUDIES WITH 3 OR MORE REGISTRATIONS THIS WEEK

ADMIN STUDYID STNAME REGTYPE Registrations
BREAST S2212 Breast, TNBC, Neoadj Chemo + Pembro 1 15
LEUK MYELOMATCH MSRP for the NCI myeloMATCH Clinical Trials 1 14
LUNG LUNGMAP NSCLC, Adv, Master 1 9
SXQOL S2013 I-CHECKIT: ICI toxicity risk prediction study 1 9
BREAST S2206 Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva 1 9
LUNG LUNGMAP NSCLC, Adv, Master 2 7
LEUK MYELOMATCH MSRP for the NCI myeloMATCH Clinical Trials 2 4
PREV NRGCC005 Colon,Non-AdvancedAdenomas,Colonoscopy5v10yrs 1 4
GU S1802 Pros, Stg IV, SST ± Surg/RT to Primary Tum 2 4
SXQOL S2205 ICE COMPRESS: Reduction of CIPN from Taxanes 1 4
GU S2427 Blad, MIBC, RT + Pembrolizumab 1 4
GU A032103 Urothelial, All Stg, MRD-Based Adj Tx 0 3
LEUK MM1YA-S01 AML, High Risk, Age <60, 7+3 vs experimental 1 3
GU S1802 Pros, Stg IV, SST ± Surg/RT to Primary Tum 1 3
LYMPH S2308 FL, LTB, Mosunetuzumab vs Rituximab 1 3
CCD S2417CD Colrec Surv, Follow-up w/ CTAC site 1 3
GU S2419 Renal, adv clear cell, IO +/- Biotx, BIOFRONT 1 3